captopril has been researched along with Coronary Artery Disease in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daphnis, E; Dermitzaki, EK; Koukouraki, S; Kyriazis, PP; Lygerou, D; Parthenakis, F; Stratakis, S; Stratigis, S; Stylianou, K; Syngelaki, P; Tsetis, D | 1 |
| Akbari, H; Asadikaram, G; Ebrahimi, G; Ebrahimi, N; Jafari, A; Masoumi, M; Nazari-Robati, M | 1 |
| Asadikaram, G; Ebrahimi, N; Kazemi Arababadi, M; Kiani, Z; Kohan, F; Masoumi, M; Nasiri, AA; Sepehri, Z; Sheikh Fathollahi, M | 1 |
| Abd Alla, J; Arman-Kalcek, G; Elzahwy, SS; Langer, A; Quitterer, U; Streichert, T | 1 |
| Ebina, T; Hibi, K; Kimura, K; Kosuge, M; Kusama, I; Morita, S; Nozawa, N; Okuda, J; Ozaki, H; Tsukahara, K; Umemura, S; Yano, H | 1 |
| Bacchelli, S; Borghi, C; Degli Esposti, D | 1 |
| Backer, CL; Crawford, SE; Huang, L; Huang, X; Mavroudis, C; Mu, Y; Pahl, E; Stellmach, V; Volpert, OV | 1 |
| Bauriedel, G; Lüderitz, B; Nickenig, G; Schneider-Schmitt, M; Skowasch, D; Viktor, A | 1 |
| Apostolakis, S; Baritaki, S; Kochiadakis, GE; Krambovitis, E; Spandidos, DA; Vlata, Z | 1 |
1 review(s) available for captopril and Coronary Artery Disease
| Article | Year |
|---|---|
Long-term clinical experience with zofenopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aspirin; Captopril; Coronary Artery Disease; Drug Interactions; Evidence-Based Medicine; Heart Failure; Humans; Hypertension; Myocardial Infarction; Platelet Aggregation Inhibitors | 2012 |
1 trial(s) available for captopril and Coronary Artery Disease
| Article | Year |
|---|---|
Effects of valsartan, an angiotensin II receptor blocker, on coronary atherosclerosis in patients with acute myocardial infarction who receive an angiotensin-converting enzyme inhibitor.
Topics: Aged; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; Blood Pressure; Captopril; Chi-Square Distribution; Coronary Artery Disease; Drug Therapy, Combination; Female; Humans; Hypertrophy, Left Ventricular; Japan; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Predictive Value of Tests; Prospective Studies; Renin-Angiotensin System; Risk Assessment; Risk Factors; Tetrazoles; Time Factors; Treatment Outcome; Ultrasonography, Interventional; Valine; Valsartan | 2012 |
7 other study(ies) available for captopril and Coronary Artery Disease
| Article | Year |
|---|---|
Renal artery stenting for atherosclerotic renal artery stenosis identified in patients with coronary artery disease: Does captopril renal scintigraphy predict outcomes?
Topics: Aged; Angiography; Angioplasty; Angiotensin-Converting Enzyme Inhibitors; Captopril; Coronary Artery Disease; Female; Humans; Hypertension, Renovascular; Kidney; Male; Middle Aged; Predictive Value of Tests; Prognosis; Radionuclide Imaging; Renal Artery; Renal Artery Obstruction; Stents | 2018 |
Atorvastatin, losartan and captopril may upregulate IL-22 in hypertension and coronary artery disease; the role of gene polymorphism.
Topics: Adult; Aged; Atorvastatin; Captopril; Case-Control Studies; Coronary Artery Disease; Female; Genotype; Humans; Hypertension; Interleukin-22; Interleukins; Iran; Losartan; Male; Middle Aged; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Up-Regulation | 2018 |
Atorvastatin, Losartan and Captopril Lead to Upregulation of TGF-β, and Downregulation of IL-6 in Coronary Artery Disease and Hypertension.
Topics: Antihypertensive Agents; Atorvastatin; Captopril; Coronary Artery Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Inflammation; Interleukin-6; Interleukin-8; Iran; Losartan; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Up-Regulation | 2016 |
Angiotensin-converting enzyme inhibition down-regulates the pro-atherogenic chemokine receptor 9 (CCR9)-chemokine ligand 25 (CCL25) axis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Captopril; Chemokines, CC; Cholesterol; Coronary Artery Disease; Down-Regulation; Female; Hematopoietic Stem Cells; Humans; Macrophages; Male; Mice; Middle Aged; Monocytes; Oligonucleotide Array Sequence Analysis; Peptidyl-Dipeptidase A; Protein Transport; Receptor, Angiotensin, Type 1; Receptors, CCR; Substrate Specificity; T-Lymphocytes | 2010 |
Captopril suppresses post-transplantation angiogenic activity in rat allograft coronary vessels.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cell Culture Techniques; Cell Movement; Cornea; Coronary Artery Disease; Disease Models, Animal; Endothelial Cells; Heart Transplantation; Male; Neovascularization, Physiologic; Platelet Activating Factor; Rats; Rats, Inbred F344; Rats, Inbred Lew; Vascular Endothelial Growth Factor A | 2004 |
Differential antiplatelet effects of angiotensin converting enzyme inhibitors: comparison of ex vivo platelet aggregation in cardiovascular patients with ramipril, captopril and enalapril.
Topics: Adenosine Diphosphate; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Cardiovascular Diseases; Clopidogrel; Collagen; Coronary Artery Disease; Electric Impedance; Enalapril; Female; Fibrinolytic Agents; Germany; Humans; Hypertension; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Ramipril; Ticlopidine; Treatment Outcome | 2006 |
CX3CR1 receptor is up-regulated in monocytes of coronary artery diseased patients: impact of pre-inflammatory stimuli and renin-angiotensin system modulators.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Case-Control Studies; Cell Line; Coronary Artery Disease; CX3C Chemokine Receptor 1; Female; Humans; In Vitro Techniques; Inflammation Mediators; Interferon-gamma; Jurkat Cells; Lisinopril; Losartan; Male; Middle Aged; Monocytes; Receptors, Chemokine; Recombinant Proteins; Renin-Angiotensin System; Tumor Necrosis Factor-alpha; Up-Regulation | 2007 |